, researchers at the Case Western Reserve University School of Medicine report that children and adolescents who contracted COVID-19 were more prone to developing T1D in the six months following their COVID diagnosis.
About 187,000 children and adolescents younger than 20 live with T1D nationally, according to the Centers for Disease Control and Prevention . The study population was further divided into two groups: patients up to age 9 years and those age 10–18 years. After careful statistical matching to account for age, demographics and family history of diabetes, there were 285,628 in each group for a total of 571,256 patients.
"Families with high risk of type 1 diabetes in their children should be especially alert for symptoms of diabetes following COVID, and pediatricians should be alert for an influx of new cases of type 1 diabetes, especially since the Omicron variant of COVID spreads so rapidly among children," Davis said."We may see a substantial increase in this disease in the coming months to years.
physorg_com JAMANetworkOpen Cool then I guess I'll die... Love sugar. Hate non-sugar... Still not getting the Pfizer/mederna farce... Had COVID 3 times still fine... Over 30, bad diet, lack of exercise, smoker(weed and menthols), no water, asthma, every thing that increases risk of death... Don't care...
JAMANetworkOpen The *experimental* vaccination should be the prime suspect. ...and, it's still experimental!
JAMANetworkOpen or the jab 😉
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system - Cardiovascular DiabetologyBackground Post-acute sequelae of COVID-19 (PASC), also now known as long COVID, has become a major global health and economic burden. Previously, we provided evidence that there is a significant insoluble fibrin amyloid microclot load in the circulation of individuals with long COVID, and that these microclots entrap a substantial number of inflammatory molecules, including those that might prevent clot breakdown. Scientifically, the most challenging aspect of this debilitating condition is that traditional pathology tests such as a serum CRP (C-reactive protein) may not show any significant abnormal inflammatory markers, albeit these tests measure only the soluble inflammatory molecules. Elevated, or abnormal soluble biomarkers such as IL-6, D-Dimer or fibrinogen indicate an increased risk for thrombosis or a host immune response in COVID-19. The absence of biomarkers in standard pathology tests, result in a significant amount of confusion for patients and clinicians, as patients are extremely sick or even bed-ridden but with no regular identifiable reason for their disease. Biomarkers that are currently available cannot detect the molecules present in the microclots we identified and are therefore unable to confirm their presence or the mechanisms that drive their formation. Methods Here we analysed the protein content of double-digested microclots of 99 long COVID patients and 29 healthy controls. The patients suffering from long COVID reported their symptoms through a questionnaire completed by themselves or their attending physician. Results Our long COVID cohort’s symptoms were found to be in line with global findings, where the most prevalent symptoms were constant fatigue (74%,) cognitive impairment (71%) and depression and anxiety (30%). Our most noteworthy findings were a reduced level of plasma Kallikrein compared to our controls, an increased level of platelet factor 4 (PF4) von Willebrand factor (VWF), and a marginally increased level of α-2 antiplasmi
Source: BioMedCentral - 🏆 22. / 71 Read more »
Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunityIn a new study, a team of researchers explored the effect of immune checkpoint blockade (ICB)-induced expansion of age-associated B cells (ABCs) on COVID-19 vaccine-derived humoral immunity in patients with cancer and inborn errors of immunity (IEI).
Source: NewsMedical - 🏆 19. / 71 Read more »
Long COVID patients show signs of autoimmune disease a year after infectionBlood samples drawn from patients with long COVID who are still suffering from fatigue and shortness of breath after a year show signs of autoimmune disease in those patients, according to a study published today in the European Respiratory Journal. EuropeanLung Interesting. The shots are causing the auto Immune disease EuropeanLung DOI link in the article is dead link fwiw
Source: medical_xpress - 🏆 101. / 51 Read more »